|Articles|November 8, 2022
Cytel Acquires SDS Life Science and SDS MedteQ
Move will add new global talent to Cytel’s Strategic Consulting group.
Advertisement
Cytel has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB. The move will add new global talent to Cytel’s Strategic Consulting group and bring additional capabilities for the strategic development of drugs and medical devices.
Read more about the acquistions
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
2
FDA Deploys Secure Agentic AI Platform to Modernize Regulatory Operations
3
Targeted and Strategy-Driven Clinical Development
4
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
